Variant report

Variant	rs530944523
Chromosome Location	chr9:2019758-2019759
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr9:2013479..2017608-chr9:2017826..2022083,7	MCF-7	breast:
2	chr9:2018308..2020609-chr9:2085608..2087272,2	K562	blood:

Variant related genes	Relation type
ENSG00000080503	Chromatin interaction

Extended variants
information (count: 14 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:14 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1016148	chr9:1457605-2361750	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
2	nsv539916	chr9:1457605-2361750	Weak transcription Genic enhancers Enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
3	nsv1021712	chr9:1647840-2216839	Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
4	nsv539921	chr9:1647840-2216839	Bivalent Enhancer Active TSS Weak transcription Strong transcription Enhancers Genic enhancers Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
5	nsv1020530	chr9:1870197-2658587	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
6	nsv831493	chr9:1885733-2074135	Weak transcription Flanking Active TSS Strong transcription Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
7	nsv892048	chr9:1888703-2177391	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	14 gene(s)	inside rSNPs	diseases
8	nsv1021158	chr9:1963930-2040728	Enhancers Strong transcription Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
9	nsv892052	chr9:1980819-2072470	Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
10	esv2830420	chr9:1998911-2119702	Strong transcription Weak transcription Enhancers Genic enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
11	nsv530929	chr9:1998911-2925112	Active TSS Weak transcription Strong transcription Flanking Active TSS Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	39 gene(s)	inside rSNPs	diseases
12	nsv613079	chr9:2012767-2059341	Enhancers Active TSS Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Strong transcription Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases
13	nsv466069	chr9:2018825-2066493	Strong transcription Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	inside rSNPs	diseases
14	nsv613080	chr9:2018825-2066493	Strong transcription Enhancers ZNF genes & repeats Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:109 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2014000-2020000	Active TSS	Right Atrium	heart
2	chr9:2014200-2021400	Active TSS	GM12878-XiMat	blood
3	chr9:2017800-2019800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
4	chr9:2018000-2020800	Flanking Active TSS	Primary hematopoietic stem cells	blood
5	chr9:2018000-2028200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr9:2018200-2019800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr9:2018200-2020200	Flanking Active TSS	Primary T cells from cord blood	blood
8	chr9:2018200-2023200	Weak transcription	Spleen	Spleen
9	chr9:2018200-2033400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr9:2018400-2023000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr9:2018400-2023000	Weak transcription	Gastric	stomach
12	chr9:2018400-2027200	Weak transcription	Esophagus	oesophagus
13	chr9:2018600-2023200	Weak transcription	Pancreas	Pancrea
14	chr9:2018800-2019800	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
15	chr9:2018800-2020200	Enhancers	Fetal Kidney	kidney
16	chr9:2018800-2021800	Weak transcription	Left Ventricle	heart
17	chr9:2019000-2020600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
18	chr9:2019000-2021800	Weak transcription	Lung	lung
19	chr9:2019000-2032800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr9:2019000-2033200	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr9:2019200-2020200	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr9:2019200-2020200	Enhancers	Primary neutrophils fromperipheralblood	blood
23	chr9:2019200-2020200	Enhancers	Fetal Heart	heart
24	chr9:2019200-2020400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr9:2019200-2020400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
26	chr9:2019200-2021800	Weak transcription	Stomach Mucosa	stomach
27	chr9:2019200-2023200	Weak transcription	Aorta	Aorta
28	chr9:2019200-2024600	Weak transcription	HSMMtube	muscle
29	chr9:2019200-2032600	Weak transcription	A549	lung
30	chr9:2019200-2039400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr9:2019400-2019800	Active TSS	Fetal Brain Female	brain
32	chr9:2019400-2020000	Enhancers	H9 Cell Line	embryonic stem cell
33	chr9:2019400-2020000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr9:2019400-2020000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
35	chr9:2019400-2020000	Enhancers	Muscle Satellite Cultured Cells	--
36	chr9:2019400-2020000	Enhancers	Brain Angular Gyrus	brain
37	chr9:2019400-2020000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
38	chr9:2019400-2020200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
39	chr9:2019400-2020200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr9:2019400-2020200	Enhancers	Brain Germinal Matrix	brain
41	chr9:2019400-2020200	Enhancers	Brain Inferior Temporal Lobe	brain
42	chr9:2019400-2020200	Enhancers	Fetal Intestine Small	intestine
43	chr9:2019400-2020200	Enhancers	Skeletal Muscle Male	skeletal muscle
44	chr9:2019400-2020400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
45	chr9:2019400-2020400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
46	chr9:2019400-2020400	Enhancers	Skeletal Muscle Female	skeletal muscle
47	chr9:2019400-2020600	Weak transcription	Duodenum Smooth Muscle	Duodenum
48	chr9:2019400-2020800	Enhancers	Liver	Liver
49	chr9:2019400-2020800	Enhancers	Brain Anterior Caudate	brain
50	chr9:2019400-2020800	Enhancers	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links